Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Alma › NPI 1023097771
Supplier

Mymichigan Medical Center Alma

Mymichigan Medical Center Alma was paid $25.31M by Medicaid between Jan 2018 and Dec 2024, across 304 billing codes. Its largest line is 99284, emergency room visit (serious) — 19% of everything it billed.

33Billing provider infoMYMICHIGAN MEDICAL CENTER ALMA
ALMA, MI 48801
33aNPI1023097771assigned 01/11/2006
33bProvider typeSpecialty Pharmacy
28Total paid$25.31M
24GClaims987,294
24DCodes billed304
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Specialty Pharmacy providers in Michigan

Rank by total paid#2 of 6
Median peer was paid$1.33M
This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official JAMES, SARAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018129,488$3.24M
2019154,776$3.51M
2020137,117$3.21M
2021181,406$4.63M
2022196,505$5.14M
2023118,100$3.37M
2024incomplete69,902$2.22M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 19% 25,961 24,072 $4.91M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 28,486 27,092 $3.43M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 10,155 9,358 $3.22M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.5% 14,146 12,754 $1.39M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 5,925 5,693 $837K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.1% 8,596 6,714 $795K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 9,846 9,553 $723K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.6% 27,689 8,515 $652K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.5% 12,100 9,624 $622K
70450 Computed tomography, head or brain; without contrast material 1.9% 4,785 4,609 $492K
96361 Intravenous infusion, hydration; each additional hour 1.9% 15,019 12,768 $482K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.8% 4,446 4,126 $443K
292 more codes
96375 Therapeutic injection; each additional sequential IV push 1.7% 13,313 $420K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 17,693 $388K
71046 Radiologic examination, chest; 2 views 1.4% 9,914 $353K
59025 Fetal non-stress test 1.3% 3,735 $338K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 1,472 $319K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 2,733 $285K
71045 Radiologic examination, chest; single view <1% 5,532 $228K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 5,602 $228K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,184 $215K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,150 $211K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 437 $205K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 14,187 $199K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,469 $173K
76830 Ultrasound, transvaginal <1% 2,696 $161K
80061 Lipid panel <1% 10,420 $144K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,369 $139K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,758 $138K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,832 $137K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,293 $129K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 5,215 $125K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 352 $124K
94060 <1% 817 $109K
97161 <1% 1,912 $103K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 635 $100K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 830 $96K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,040 $88K
97162 <1% 1,568 $78K
76801 <1% 1,222 $75K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 346 $72K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,166 $70K
G0378 Hospital observation service, per hour <1% 2,998 $70K
G0379 Direct admission of patient for hospital observation care <1% 107 $69K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,433 $66K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,377 $66K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,429 $64K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,383 $54K
93971 <1% 943 $53K
84443 Thyroid stimulating hormone (TSH) <1% 17,270 $51K
80053 Comprehensive metabolic panel <1% 50,866 $50K
96367 <1% 1,328 $50K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 427 $48K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 55,151 $39K
72100 <1% 1,125 $37K
73630 <1% 3,081 $36K
76857 <1% 648 $36K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,486 $33K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,764 $30K
76770 <1% 505 $29K
76536 <1% 521 $28K
72125 Computed tomography, cervical spine; without contrast material <1% 1,739 $27K
36591 <1% 512 $27K
72131 <1% 531 $26K
73030 <1% 1,829 $26K
73564 <1% 1,566 $26K
86900 <1% 3,319 $26K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,553 $25K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 532 $23K
73610 <1% 2,208 $22K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 57 $22K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,032 $22K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening <1% 2,716 $21K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 145 $20K
73130 <1% 2,194 $20K
93225 <1% 468 $19K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,569 $18K
83036 Hemoglobin; glycosylated (A1C) <1% 8,213 $18K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,825 $18K
76642 <1% 387 $17K
82607 <1% 4,407 $17K
97116 <1% 1,201 $16K
73110 <1% 1,342 $16K
36415 Collection of venous blood by venipuncture <1% 53,636 $16K
L4350 Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf <1% 285 $15K
74018 <1% 1,157 $14K
82728 <1% 4,416 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,736 $14K
71271 <1% 202 $13K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,991 $13K
87653 <1% 1,216 $12K
97597 <1% 181 $12K
73562 <1% 453 $12K
73502 <1% 699 $11K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 1,167 $10K
82746 <1% 2,597 $9K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 137 $8K
87808 <1% 2,698 $8K
86803 <1% 2,273 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 859 $8K
70491 <1% 81 $8K
70496 <1% 128 $8K
80306 <1% 5,980 $8K
84439 <1% 4,110 $8K
80048 Basic metabolic panel (calcium, ionized) <1% 7,010 $7K
83550 <1% 3,585 $7K
87081 <1% 10,205 $7K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 14 $7K
71250 <1% 160 $7K
84702 <1% 2,798 $7K
93017 <1% 180 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 6,631 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 19,070 $6K
80074 <1% 583 $6K
97533 <1% 210 $6K
64493 <1% 14 $6K
87186 <1% 4,208 $6K
83540 <1% 3,950 $6K
88342 <1% 391 $6K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 12 $6K
85027 <1% 4,076 $5K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 343 $5K
82951 <1% 1,097 $5K
81001 <1% 29,805 $5K
73080 <1% 397 $4K
88304 <1% 1,003 $4K
80055 <1% 298 $4K
72141 <1% 24 $4K
70486 <1% 93 $4K
87088 <1% 3,181 $4K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 12 $4K
78227 <1% 14 $4K
87077 <1% 2,855 $4K
82043 <1% 2,366 $3K
83735 <1% 12,260 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,805 $3K
86592 <1% 1,990 $3K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 194 $3K
87070 <1% 1,801 $3K
74183 <1% 12 $3K
87075 <1% 1,947 $3K
83880 <1% 3,491 $3K
86140 <1% 9,006 $2K
72040 <1% 80 $2K
87340 <1% 1,392 $2K
86038 <1% 807 $2K
84146 <1% 513 $2K
72110 <1% 136 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,349 $2K
85610 <1% 8,005 $2K
73590 <1% 347 $2K
87220 <1% 2,318 $2K
87205 <1% 1,996 $2K
80076 <1% 977 $2K
77066 Tomosynthesis, mammo <1% 29 $2K
92523 <1% 12 $2K
83970 <1% 117 $2K
74019 <1% 79 $2K
93970 <1% 14 $2K
85730 <1% 4,218 $1K
83690 <1% 10,548 $1K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 246 $1K
97163 <1% 28 $1K
87276 <1% 11,013 $1K
82570 <1% 969 $1K
85652 <1% 3,735 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 726 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 66 $1K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 94 $1K
84100 <1% 1,302 $1K
29515 <1% 14 $1K
96417 <1% 22 $1K
81025 <1% 11,272 $1K
86850 <1% 3,053 $1K
82784 <1% 233 $1K
87275 <1% 11,013 $1K
86703 <1% 534 $968.86
87430 <1% 8,284 $943.65
82550 <1% 1,372 $785.19
73090 <1% 245 $781.93
84481 <1% 155 $754.87
77080 <1% 12 $716.77
84703 <1% 3,370 $668.30
84403 <1% 84 $659.52
77065 Tomosynthesis, mammo <1% 13 $600.32
74022 <1% 203 $600.22
87427 <1% 127 $583.48
87807 <1% 3,609 $547.65
86431 <1% 409 $498.46
70498 <1% 102 $483.43
94726 <1% 340 $442.01
84550 <1% 458 $423.28
82565 <1% 298 $422.96
82947 <1% 350 $416.75
72072 <1% 12 $407.82
83615 <1% 427 $399.76
83516 <1% 99 $367.02
85379 <1% 4,187 $360.44
83001 <1% 81 $335.91
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 14 $316.20
85576 <1% 40 $301.03
86901 <1% 3,317 $299.09
76870 <1% 13 $285.20
81002 <1% 467 $270.27
90715 <1% 659 $244.44
82105 <1% 42 $243.76
82140 <1% 219 $241.30
87046 <1% 108 $237.12
87045 <1% 108 $237.12
84153 <1% 38 $236.04
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,505 $228.00
86762 <1% 436 $214.84
83605 <1% 10,225 $153.34
87040 <1% 2,523 $151.52
84480 <1% 39 $148.33
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 14 $131.04
84484 <1% 9,884 $130.63
71101 <1% 13 $129.68
82670 <1% 12 $123.33
86141 <1% 25 $116.83
82248 <1% 110 $113.81
85046 <1% 74 $109.13
82962 <1% 8,175 $104.84
86308 <1% 431 $101.39
84145 <1% 1,948 $100.62
51798 <1% 290 $97.79
84156 <1% 91 $88.10
80164 <1% 28 $59.72
86200 <1% 12 $56.43
84520 <1% 42 $52.36
87338 <1% 12 $45.45
12001 <1% 551 $42.36
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 333 $36.59
87449 <1% 14 $30.12
87324 <1% 25 $30.12
86706 <1% 12 $26.72
82310 <1% 14 $22.93
80069 <1% 16 $21.03
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,686 $20.76
82010 <1% 393 $20.13
82040 <1% 13 $18.75
29125 <1% 63 $17.35
85018 <1% 49 $12.15
85014 <1% 32 $11.59
82803 <1% 599 $10.65
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,295 $9.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,810 $8.99
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,838 $7.56
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,959 $5.64
J1170 Injection, hydromorphone, up to 4 mg <1% 4,789 $3.86
A9270 Non-covered item or service <1% 2,652 $2.10
J0690 Injection, cefazolin sodium, 500 mg 0% 1,233 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 1,709 $0.00
J2060 Injection, lorazepam, 2 mg 0% 1,273 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 3,478 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 752 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 998 $0.00
96376 0% 3,558 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 1,937 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 2,711 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 350 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 1,071 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 3,093 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 201 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 1,248 $0.00
J2704 Injection, propofol, 10 mg 0% 1,308 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 174 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 16 $0.00
96368 0% 243 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 28 $0.00
J2805 Injection, sincalide, 5 micrograms 0% 13 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 105 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 14 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 22 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 31 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 12 $0.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 0% 20 $0.00
64494 0% 19 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 13 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 643 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 372 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 503 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 991 $0.00
93226 0% 468 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 4,228 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 1,307 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 1,804 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 29 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 23 $0.00
94729 0% 395 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 239 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 68 $0.00
86318 0% 26 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 331 $0.00
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf 0% 39 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 102 $0.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 0% 26 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 57 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 35 $0.00
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf 0% 44 $0.00
12011 0% 13 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 13 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 17 $0.00
J1020 Injection, methylprednisolone acetate, 20 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJAMES, SARAH (MANAGER, PROVIDER ENROLLMENT)
Same official

Other billing entities under JAMES, SARAH

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.